Renal Trajectory of Eligible Simultaneous Liver–Kidney Transplant Recipients
Livers · 13.05.2026 · 6 (3) · 42
DOI: 10.3390/livers6030042 ↗Kurz gefasst
Fachartikel in der Zeitschrift Livers, online erschienen am 13.05.2026. Verfasst von Manuj Mayank Shah und 14 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Simultaneous liver–kidney transplantation (SLK) eligible candidates may receive SLK or liver-alone transplant (LA) with access to kidney transplant after initial LA (KAL). We aimed to characterize SLK-eligible recipient outcomes according to treatment approach.
Methods
This study utilized 2017–2023 SRTR data to identify SLK-eligible deceased donor liver transplants. Recipients were placed into two groups based on whether SLK was performed; non-SLK patients were sub-stratified into LA and KAL cohorts. After baseline comparisons, 2-year patient and graft survival outcomes were characterized by univariable and multivariable Cox proportional hazard regression and Kaplan–Meier analysis.
Results
Among 4879 candidates identified, 3746 (76.8%) underwent SLK, 1023 (21.0%) LA, and 110 (2.3%) KAL. SLK recipients maintained the highest eGFRs at 6 months, 1 year, and 2 years post-transplant (p < 0.01). Compared to SLK recipients, non-SLK recipients had a higher 2-year risk of mortality (aHR 2.46, p < 0.01), all-cause events (aHR 1.91, p < 0.01), and liver graft failure (HR 1.55, p = 0.02). LA conferred a higher 2-year mortality risk (aHR 2.98, p < 0.01) and all-cause event risk (aHR 2.25, p < 0.01), while KAL had comparable mortality risk to SLK (aHR 0.43, p = 0.40).
Conclusions
When SLK-eligible candidates undergo transplants, SLK remains the optimal path forward, even when a safety net kidney can be performed.
Zitieren
APA
Shah, M. M., Hussain, S., Hapuarachchy, B., Jenkins, R. T., Farhat, D. J., McDade, H., Kassam, A., King, E. A., Wesson, R., Weeks, S., Cameron, A. M., Massie, A. B., Segev, D. L., Gurakar, A., & Philosophe, B. (2026). Renal Trajectory of Eligible Simultaneous Liver–Kidney Transplant Recipients. Livers, 6(3), 42. https://doi.org/10.3390/livers6030042
Vancouver
Shah MM, Hussain S, Hapuarachchy B, Jenkins RT, Farhat DJ, McDade H, et al. Renal Trajectory of Eligible Simultaneous Liver–Kidney Transplant Recipients. Livers. 2026;6(3):42. doi:10.3390/livers6030042
BibTeX
@article{Shah2026,
author = {Shah, Manuj Mayank and Hussain, Sarah and Hapuarachchy, Binuri and Jenkins, Reed Towle and Farhat, David J. and McDade, Heather and Kassam, Al-Faraaz and King, Elizabeth A. and Wesson, Russell and Weeks, Sharon and Cameron, Andrew M. and Massie, Allan B. and Segev, Dorry L. and Gurakar, Ahmet and Philosophe, Benjamin},
title = {Renal Trajectory of Eligible Simultaneous Liver–Kidney Transplant Recipients},
journal = {Livers},
year = {2026},
volume = {6},
number = {3},
pages = {42},
doi = {10.3390/livers6030042}
}
EUVIMED